← Eichor
Study identifier: NCT07417904 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis

Condition: Violence Risk · Early Psychosis  ·  Sponsor: Howard University

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to 30 Years
Healthy volunteersNo

About this study

This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.

This description comes directly from the study's public registry record.

Talk to the study team

Stephanie Rolin, MD MPH  ·  (202) 865-6100  ·  stephanie.rolin@howard.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Howard University HospitalWashington D.C., District of Columbia, United StatesNot Yet Recruiting
Howard University HospitalWashington D.C., District of Columbia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07417904